These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
362 related items for PubMed ID: 33896317
1. An update on brivaracetam for the treatment of pediatric partial epilepsy. Tulli E, Di Cara G, Iapadre G, Striano P, Verrotti A. Expert Opin Pharmacother; 2021 Aug; 22(11):1387-1395. PubMed ID: 33896317 [Abstract] [Full Text] [Related]
2. Potential role of brivaracetam in pediatric epilepsy. Verrotti A, Grasso EA, Cacciatore M, Matricardi S, Striano P. Acta Neurol Scand; 2021 Jan; 143(1):19-26. PubMed ID: 32966640 [Abstract] [Full Text] [Related]
3. Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy. Klein P, Bourikas D. Adv Ther; 2024 Jul; 41(7):2682-2699. PubMed ID: 38811492 [Abstract] [Full Text] [Related]
6. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures. Mumoli L, Palleria C, Gasparini S, Citraro R, Labate A, Ferlazzo E, Gambardella A, De Sarro G, Russo E. Drug Des Devel Ther; 2015 Jul; 9():5719-25. PubMed ID: 26543353 [Abstract] [Full Text] [Related]
7. Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center. Green SF, Hare N, Kassam M, Rugg-Gunn F, Koepp MJ, Sander JW, Rajakulendran S. Epilepsy Behav; 2022 Oct; 135():108868. PubMed ID: 35985166 [Abstract] [Full Text] [Related]
8. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST). Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C, BRIVAFIRST Group Membership. CNS Drugs; 2021 Dec; 35(12):1289-1301. PubMed ID: 34476770 [Abstract] [Full Text] [Related]
9. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial. Biton V, Berkovic SF, Abou-Khalil B, Sperling MR, Johnson ME, Lu S. Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953 [Abstract] [Full Text] [Related]
10. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial. Ryvlin P, Werhahn KJ, Blaszczyk B, Johnson ME, Lu S. Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083 [Abstract] [Full Text] [Related]
11. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability. Foo EC, Geldard J, Peacey C, Wright E, Eltayeb K, Maguire M. Epilepsy Behav; 2019 Oct; 99():106505. PubMed ID: 31493736 [Abstract] [Full Text] [Related]
12. Adjunctive brivaracetam - A prospective audit of outcomes from an epilepsy clinic. Stephen L, Brodie MJ. Epilepsy Behav; 2021 Mar; 116():107746. PubMed ID: 33517200 [Abstract] [Full Text] [Related]
13. Brivaracetam for the treatment of epilepsy. Schulze-Bonhage A. Expert Opin Pharmacother; 2011 Aug; 12(12):1959-66. PubMed ID: 21682662 [Abstract] [Full Text] [Related]
19. Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany. Steinig I, von Podewils F, Möddel G, Bauer S, Klein KM, Paule E, Reif PS, Willems LM, Zöllner JP, Kunz R, Runge U, Kurlemann G, Schubert-Bast S, Rosenow F, Strzelczyk A. Epilepsia; 2017 Jul; 58(7):1208-1216. PubMed ID: 28480518 [Abstract] [Full Text] [Related]